Literature DB >> 15893414

Vessel dilator: most potent of the atrial natriuretic peptides in decreasing the number and DNA synthesis of human squamous lung cancer cells.

Brian A Vesely1, Shannon R Fitz, William R Gower, David L Vesely.   

Abstract

Within 24 h four peptide hormones, i.e. vessel dilator, long acting natriuretic peptide, kaliuretic peptide, and atrial natriuretic peptide and their intracellular mediator cyclic GMP decreased the number of human squamous lung cancer cells 51, 22, 25, 21, and 30%, respectively. There was not any proliferation in the 3 days following this decrease in cell number. Vessel dilator decreased DNA synthesis 85% in the squamous lung cancer cells. Thus, vessel dilator significantly decreased the number of human squamous lung cancer cells and their DNA synthesis, mediated in part by cyclic GMP, more than other peptide hormones.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 15893414     DOI: 10.1016/j.canlet.2005.03.024

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  9 in total

1.  Four peptides decrease human colon adenocarcinoma cell number and DNA synthesis via cyclic GMP.

Authors:  William R Gower; Brian A Vesely; Abdel A Alli; David L Vesely
Journal:  Int J Gastrointest Cancer       Date:  2005

Review 2.  The multifaceted role of natriuretic peptides in metabolic syndrome.

Authors:  Prasanna K Santhekadur; Divya P Kumar; Mulugeta Seneshaw; Faridoddin Mirshahi; Arun J Sanyal
Journal:  Biomed Pharmacother       Date:  2017-06-07       Impact factor: 6.529

3.  Association between brain natriuretic peptide and distant metastases in advanced non-small cell lung cancer patients.

Authors:  Katsuhiro Masago; Shiro Fujita; Yosuke Togashi; Kaoru Irisa; Yuichi Sakamori; Yukimasa Hatachi; Akiko Fukuhara; Hiroki Nagai; Young Hak Kim; Tadashi Mio; Michiaki Mishima
Journal:  Oncol Lett       Date:  2011-01-21       Impact factor: 2.967

Review 4.  Evaluation of the use of therapeutic peptides for cancer treatment.

Authors:  Susan Marqus; Elena Pirogova; Terrence J Piva
Journal:  J Biomed Sci       Date:  2017-03-21       Impact factor: 8.410

5.  Four cardiac hormones eliminate up to 82% of human medullary thyroid carcinoma cells within 24 hours.

Authors:  Ehrentraud J Eichelbaum; Brian A Vesely; Abdel A Alli; Ying Sun; William R Gower; David L Vesely
Journal:  Endocrine       Date:  2006-12       Impact factor: 3.925

6.  Cardiac Hormones Target the Ras-MEK 1/2-ERK 1/2 Kinase Cancer Signaling Pathways.

Authors:  David L Vesely
Journal:  Cancers (Basel)       Date:  2011-03-08       Impact factor: 6.639

7.  Atrial natriuretic peptide: a magic bullet for cancer therapy targeting Wnt signaling and cellular pH regulators.

Authors:  A Serafino; P Pierimarchi
Journal:  Curr Med Chem       Date:  2014       Impact factor: 4.530

Review 8.  Modified natriuretic peptides and their potential roles in cancer treatment.

Authors:  Mengjiao Xu; Xingzhu Liu; Ping Li; Yadong Yang; Wenyuan Zhang; Siyu Zhao; Ying Zeng; Xile Zhou; Ling-Hui Zeng; Geng Yang
Journal:  Biomed J       Date:  2021-07-06       Impact factor: 7.892

9.  Peptidome characterization of ovarian cancer serum and the identification of tumor suppressive peptide ZYX36-58.

Authors:  Xusu Wang; Guangquan Liu; Na Sheng; Mi Zhang; Xinxing Pan; Siyu Liu; Ke Huang; Yu Cong; Qing Xu; Xuemei Jia; Juan Xu
Journal:  Ann Transl Med       Date:  2020-08
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.